EndBrainCancer Initiative retweeted
Exciting news yesterday as $PSTV was able to share our recent $3 Million DoD Award for our ReSPECT-PBC Pediatric Brain Cancer Trial.
Stock Region Article: bit.ly/4b4OBXG
#Nasdaq #ClinicalResearch #ClinicalTrial #PediatricOncology #BrainCancer
EndBrainCancer Initiative retweeted
I was wrong! Looks like the next brain tumor drug that will probably be approved is tovorafenib! It has a PDUFA date of 4/30/2024! (A PDUFA date is the target date for the FDA to make a decision. It is usually close!) This is for pediatric low grade glioma!
EndBrainCancer Initiative retweeted
JUST RELEASED: The inaugural #NationalCancerPlan assessment report, curated by @PresCancerPanel, which offers key recommendations to expedite progress to #EndCancerAsWeKnowIt. Discover the five priority areas highlighted by the panel here: spr.ly/6019XGf0z

ALT On a green background, white text reads, "Our five priorities are united by the ultimate goal of ensuring that every person in the United States has equitable access to the best possible resources and care for cancer risk reduction, detection, treatment, and survivorship." A banner below reads, "President's Cancer Panel Initial Assessment of the National Cancer Plan: A Report to the President of the United States."
EndBrainCancer Initiative retweeted
Dr. Herschman, Dr. Hatoum & Dr. Garcia at @HCAFLHealthcare pioneered #GammaTile®, FDA-cleared #brachytherapy, a breakthrough in #braintumortreatment delivering #radiation at surgery to eradicate residual #tumor cells. Know more: hubs.la/Q02mpSKH0
EndBrainCancer Initiative retweeted
Plus Therapeutics to Announce Q4 and Full Year 2023 Financial Results on March 5, 2024
Webcast Link: edge.media-server.com/mmc/p/…
Press Release: bit.ly/PSTV_PR
#Financials #Pharma #Oncology #RareDisease #Patients #HealthCare #Cancer #Radiotherapeutics #ClinicalTrials $PSTV
EndBrainCancer Initiative retweeted
We had a great time at the @SSBTR Cure-A-Thon last weekend! We are grateful to all who joined us in raising awareness of the need for new brain tumor care. Thank you to SSBTR for their support in furthering our research. To help support our mission, visit: loom.ly/_yMV5BU
EndBrainCancer Initiative retweeted
It is critical that DNA-based genomic profiling (CGP) tests are optimally designed to identify fusions, which are important driver events that can significantly influence treatment decisions & patient outcomes: bit.ly/42SSZpU
EndBrainCancer Initiative retweeted
Dr. @NaderSanai presented encouraging findings this morning at #SNO2023 from a Phase 0/2 clinical trial of niraparib. We're excited about further exploring the potential role of this drug with @GSK for patients with MGMT-unmethylated #glioblastoma.
📰: loom.ly/hRvEPnA
EndBrainCancer Initiative retweeted
If you haven't had a chance to come by our booth at the Society for Neuro-Oncology Annual Meeting, we will be here through Sunday and would love to meet you
#ClinicalTrials #Glioblastoma #GBM #Metastasis #BrainCancer #BreastCancer #LungCancer #Healthcare #Data $PSTV
EndBrainCancer Initiative retweeted
Plus Therapeutics is at the Society for Neuro-Oncology Annual Meeting in Vancouver! Come see our 4 posters, which we will formally present tonight. The posters will also be available on our website after the meeting.
#ClinicalTrials #GBM #BrainCancer #Healthcare #Data $PSTV
EndBrainCancer Initiative retweeted
Insightful presentation by Dr. @charutafurey!👏 She discusses the Ivy Center’s first reported experience of serial CSF liquid biopsy to monitor DNA- and RNA-based tumor evolution in the context of an experimental therapy.
EndBrainCancer Initiative retweeted
An enlightening panel including our Ivy Center CMO, Dr. @YoshieUmemura, at the #SNO2023 Clinical Trial Design Workshop! Dr. Umemura shared her expertise in developing and leading neuro-oncology clinical trials.🥼 @NeuroOnc
EndBrainCancer Initiative retweeted
WATCH: Dr. Mioara Larion investigates life-sustaining chemical reactions— known as metabolism—that fuel tumor growth. Her lab @NIHBrainTumor aims to better understand #CancerMetabolism so that less toxic treatments can be created for people with #CNStumors spr.ly/6015utWqx
Targeting Cancer Metabolism
EndBrainCancer Initiative retweeted
New #Collaboration #Announcement – Foundation Medicine & @PierreFabre to collaborate to develop Foundation Medicine’s high-quality genomic tests as companion diagnostics for new #targetedtherapies to treat patients w/ NSCLC. Read more: bit.ly/3QYdj4F
EndBrainCancer Initiative retweeted
Meet us at the Society for Neuro-Oncology (SNO) Annual Meeting @NeuroOnc in Vancouver today! Visit booth 405 to learn more about GammaTile! We are looking forward to seeing you.
#gammatile #neurooncology #neurosurgery #SNO2023
EndBrainCancer Initiative retweeted
#LSINW23 - The next set of company/research institution presentations is underway! Hear from leading #ArtificialIntelligence, #Oncology & #RareDisease, and #ResearchTools & #MedTech organizations that are making advancements in their fields.
EndBrainCancer Initiative retweeted
jamanetwork.com/journals/jam…
The DCVAX peer reviewed journal article is now available online!
#DCVAX #SNO2022 #GBM
EndBrainCancer Initiative retweeted
I feel it address all of the criticisms we heard from the May report!
EndBrainCancer Initiative retweeted
"By patients, for patients" — here's to the spirit of the #CancerMoonshot on GBM Awareness Day. #GBMDay #Glioblastomaawarenessday #GBM #glioblastoma
EndBrainCancer Initiative retweeted
The @EndBrainCancer Initiative recognizes individuals in the #GBM community by providing a platform for sharing experiences. True stories can be validating for others around us. #GBMDay


























